Видео ютуба по тегу Icml 2017 Non-Hodgkin Lymphoma

ADCT-402 - a drug to watch
ADCT-402 - a drug to watch
An overview of the current treatment landscape of non-Hodgkin lymphoma
An overview of the current treatment landscape of non-Hodgkin lymphoma
Facebook Live Webchat: Non-Hodgkin Lymphoma
Facebook Live Webchat: Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
Active Monitoring (watch and wait) for low-grade non-Hodgkin lymphoma
Active Monitoring (watch and wait) for low-grade non-Hodgkin lymphoma
What is low-grade non-Hodgkin lymphoma?
What is low-grade non-Hodgkin lymphoma?
Dr. Kahl on ADCT-402 for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Dr. Kahl on ADCT-402 for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Understanding Bispecific Antibodies
Understanding Bispecific Antibodies
Revolutionary immunotherapy for lymphoma
Revolutionary immunotherapy for lymphoma
Non-Hodgkin’s Lymphoma: Exploring Subtypes
Non-Hodgkin’s Lymphoma: Exploring Subtypes
Non-Hodgkin's lymphoma (NHL) B-cell and T-cell | Aggressive and Indolent
Non-Hodgkin's lymphoma (NHL) B-cell and T-cell | Aggressive and Indolent
ViPOR regimen for R/R B-cell lymphoma
ViPOR regimen for R/R B-cell lymphoma
Non-Hodgkin's Lymphoma | Phillip Beron, MD - UCLA Health
Non-Hodgkin's Lymphoma | Phillip Beron, MD - UCLA Health
CD47-targeting antibody: targeting the source of non-Hodgkin lymphoma
CD47-targeting antibody: targeting the source of non-Hodgkin lymphoma
Lymphoma Focus Day Low grade non Hodgkin lymphoma Rob Lown
Lymphoma Focus Day Low grade non Hodgkin lymphoma Rob Lown
2017 ASH MHM: Focus on Lymphoma – John Leonard, MD, and Jonathan Friedberg, MD
2017 ASH MHM: Focus on Lymphoma – John Leonard, MD, and Jonathan Friedberg, MD
Emerging Therapies for Non Hodgkin's Lymphoma (NHL)
Emerging Therapies for Non Hodgkin's Lymphoma (NHL)
Developments in B-cell lymphoma management
Developments in B-cell lymphoma management